|
|
 |
|
|
|
|
Course Overview
|
Recognition, Management and Surveillance of Ricin-Associated Illness
Centers for Disease Control and Prevention
Public Health Training Network Webcast
Originally aired December 30, 2003
Continuing Education Credit is available until January 6, 2007
View Webcast
|
The threat of overt or covert chemical terrorism is increasing
in the United States. A recent event in New Sweden, Maine,
in which arsenic was deliberately added to coffee at a
church function illustrates the need for proactive education
of clinicians and public health authorities regarding chemical-associated
illness. The discovery of a package containing ricin and a threatening note
at a South Carolina Postal Office in October of 2003 highlighted the need
for periodic focused education on a particular agent.
This Webcast will provide clinicians and public health officials
with the most up-to-date information available on the following areas:
recognition, management, and disposition of patients with ricin-associated
illness; identification of epidemiologic clues possibly associated with
a covert ricin release; and disposition of patients with suspected
ricin-associated illness.
|
Goals
-
To provide clinicians and public health officials with the
following information related to ricin: background, clinical presentation,
recognition and diagnosis, management, personal protective equipment/decontamination,
and reporting.
-
To provide clinicians and public health officials with information on
epidemiological clues that may suggest illness associated with ricin
(or other chemical/biological toxins) in the correct clinical context.
|
Objectives
Upon successful completion of the program, participants should be able to:
- Explain where ricin is found
- Describe the epidemiology of non-terrorism associated ricin poisoning
- Describe the epidemiology of terrorism associated ricin poisoning
- Describe the clinical manifestations of oral, inhalational, and parenteral ricin poisoning
- Describe differential diagnosis for ricin poisoning
- Explain the diagnosis of ricin poisoning
- Identify epidemiological clues suggestive of a possible covert ricin (or other chemical/biological toxin) release
- Describe the clinical management of ricin poisoning
- Describe the disposition of patients with ricin-associated illness
- Identify the proper authorities for reporting of suspected or known ricin-associated illness
|
Target Audience
Physicians, nurses, nurse practitioners, physician assistants,
Emergency physicians, primary care physicians, critical care physicians,
nurse practitioners, physician assistants, public health agency officials,
policy makers, and academic institutions
|
Faculty
LCDR Joshua G. Schier, MD USPHS, Medical Toxicologist, Health Studies Branch,
National Center for Environmental Health, Centers for Disease Control and Prevention
|
Questions
To interact with faculty and participate in learning,
you may submit questions via email to ricinquestions@cdc.gov
after the webcast.
Questions and answers will be posted on the Course Overview
website at http://www.phppo.cdc.gov/PHTN/ricin/.
|
Registration and Continuing Education Information
Participants are encouraged but not required to register and evaluate the webcast. Registration and evaluation will provide valuable feedback to CDC.
A certificate of credit or a certificate of attendance will be awarded to participants who complete the evaluation.
Participant registration will only be available through the CDC/ATSDR
Training and Continuing Education Online System at
http://www.phppo.cdc.gov/phtnonline.
Course numbers are listed below:
WD0035 - web-on-demand
CB3093 - CD-ROM
The Centers for Disease Control and Prevention is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to
provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this educational
activity for maximum of 1 category 1 credit toward the AMA Physician's
Recognition Award. Each physician should claim only those credits that
he/she actually spent in the activity.
This activity for 1 contact hour is provided by the Centers for Disease
Control and Prevention, which is accredited as a provider of continuing
education in nursing by the American Nurses Credentialing Center's Commission
on Accreditations.
The Centers for Disease Control and Prevention is a designated
provider of continuing education contact hours (CECH) in health
education by the National Commission for Health Education Credentialing,
Inc. This program is a designated event for the CHES to receive 1 Category
I contact hour in health education, CDC provider number GA0082.
The Centers for Disease Control and Prevention has been approved as an
Authorized Provider of continuing education and training programs by
the International Association for Continuing Education and Training
and awards 0.1 Continuing Education Units (CEUs).
Questions about registration should be directed to
800-41-TRAIN, 404-639-1292, or email ce@cdc.gov.
When emailing a question, please indicate Recognition, Management and
Surveillance of Ricin-Associated Illness in the subject line.
Additional Resources
|
Webcast Information
This program is available for viewing as an
archived webcast.
|
Media
Following the live webcast, the program will be available as an
archived webcast and on CD-ROMs.
CD-ROMs
CD-ROMs are available from the Public Health Foundation (PHF).
Single copies are free of charge while supplies last.
Order online at http://www.phf.org or by calling 877-252-1200.
Sponsors
National Center for Environmental Health, the Public Health Training Network,
the Division of Professional Development and Evaluation, Public Health
Practice Program Office, CDC
|
This page last reviewed: August 4, 2004
|
|
